Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Geron Corporation is a late-stage clinical biopharmaceutical company dedicated to the development and potential commercialization of imetelstat, a novel, first-in-class telomerase inhibitor. Their primary focus is on treating hematologic myeloid malignancies, such as lower risk myelodysplastic syndromes (MDS) and refractory myelofibrosis (MF). Geron's vision is to become a leader in this therapeutic area, aiming to provide new treatment options for patients with significant unmet medical needs.
The headquarters serves as the central hub for Geron's corporate leadership, strategic planning, research and development oversight, clinical operations management, financial operations, and administrative functions.
Located in a prominent business park within the San Francisco Bay Area, a key biotech hub, the headquarters provides modern office facilities conducive to collaboration and scientific innovation.
Geron fosters a science-driven and patient-focused work culture. It emphasizes innovation, rigorous scientific research, collaboration among teams, and a commitment to ethical practices in the development of new cancer therapies.
The Foster City headquarters is critical for Geron's operations, housing the core decision-making executives and teams that drive the company's drug development programs, regulatory interactions, and preparations for potential commercialization.
Geron Corporation's global presence is primarily defined by its clinical trial operations for imetelstat, which are conducted across North America, Europe, and Asia. While its corporate functions are centralized in the U.S., the company engages with international regulatory bodies like the European Medicines Agency (EMA) and collaborates with global research institutions and clinical sites to advance its therapeutic programs for patients worldwide.
919 E. Hillsdale Blvd., Suite 250
Foster City
CA
United States
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Geron Corporation' leadership includes:
Geron Corporation has been backed by several prominent investors over the years, including:
Over the past 12 months (since May 2023), Geron Corporation announced one key appointment to its executive leadership team, strengthening its human resources capabilities. No major executive departures have been publicly announced during this period.
Discover the tools Geron Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Geron Corporation primarily uses the 'first initial + last name' or 'first name initial + last name' email format. For example, if an employee is named Jane Doe, her email address is likely jdoe@geron.com.
[first_initial][last]@geron.com
Format
jdoe@geron.com
Example
85%
Success rate
Geron Press Release • May 7, 2024
Geron reported its first quarter 2024 financial results and provided updates on recent corporate events, including progress with its lead drug candidate imetelstat and preparations for potential U.S. launch in lower risk MDS....more
Geron Press Release • March 19, 2024
Geron announced the pricing of an underwritten public offering of its common stock, with proceeds intended for commercialization activities for imetelstat, research and development, and general corporate purposes....more
Geron Press Release • August 22, 2023
The U.S. Food and Drug Administration (FDA) accepted Geron's New Drug Application (NDA) for imetelstat for treating transfusion-dependent anemia in adult patients with lower risk myelodysplastic syndromes (MDS). The FDA assigned a Prescription Drug User Fee Act (PDUFA) target action date of June 16, 2024....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Geron Corporation, are just a search away.